For those pancreatic cancer patients with high RRM1 expression in their tumors, adjuvant chemotherapy with gemcitabine together with RRM1 inhibition might be an attractive treatment strategy leading to better postoperative outcomes. Here, RRM1 is linked to pancreatic neoplasm.